The effect of chromium administration on the mean serum levels of HbA1C, FBS and 2hpp in diabetic patients
Phase 3
Recruiting
- Conditions
- Diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20190618043934N19
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Age over 40 years
Patients with type 2 diabetes
Having diabetes for at least 6 months
Patients treated with oral medication
Glycosylated hemoglobin below 9
Exclusion Criteria
Patients consuming minerals, vitamins or antioxidants or medicinal plants
Pregnant or lactating women
Heart failure disease
Having another chronic disease
Treatment of hyperlipidemia
Having complications of diabetes including retinopathy, neuropathy and nephropathy
Receive insulin
Patients with kidney and liver failure
Patients undergoing treatment for gastrointestinal diseases
Thyroid problems, either hypo or hyperthyroid
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Sugar. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit.;Glycosylated hemoglobin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit.;Fasting blood sugar 2 hours after eating. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit.
- Secondary Outcome Measures
Name Time Method